Group One Trading’s Bristol-Myers Squibb BMY Stock Holding History

Group One Trading’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.6M	Sell	240,000 -169,800	-41%	-$9.9M	0.03%	638
2025 Q4	$22.1M	Buy	409,800 +38,400	+10%	+$1.85M	0.04%	487
2025 Q3	$16.8M	Sell	371,400 -32,800	-8%	-$1.53M	0.03%	582
2025 Q2	$18.7M	Buy	404,200 +43,200	+12%	+$2.12M	0.04%	463
2025 Q1	$22M	Buy	361,000 +33,000	+10%	+$1.92M	0.06%	285
2024 Q4	$18.6M	Sell	328,000 -2,300	-0.7%	-$129K	0.04%	415
2024 Q3	$17.1M	Buy	330,300 +103,600	+46%	+$4.86M	0.05%	339
2024 Q2	$9.41M	Buy	226,700 +130,700	+136%	+$5.85M	0.04%	475
2024 Q1	$5.21M	Sell	96,000 -305,500	-76%	-$15.6M	0.02%	805
2023 Q4	$20.6M	Buy	401,500 +316,400	+372%	+$16.6M	0.05%	334
2023 Q3	$4.94M	Buy	85,100 +17,000	+25%	+$1.04M	0.02%	950
2023 Q2	$4.35M	Buy	68,100 +38,300	+129%	+$2.57M	0.01%	1064
2023 Q1	$2.07M	Sell	29,800 -239,000	-89%	-$16.9M	0.01%	1495
2022 Q4	$19.3M	Sell	268,800 -136,700	-34%	-$10.3M	0.05%	421
2022 Q3	$28.8M	Sell	405,500 -50,600	-11%	-$3.67M	0.06%	261
2022 Q2	$35.1M	Sell	456,100 -181,500	-28%	-$13.8M	0.06%	278
2022 Q1	$46.6M	Sell	637,600 -233,100	-27%	-$15.7M	0.05%	275
2021 Q4	$54.3M	Buy	870,700 +488,900	+128%	+$28.7M	0.04%	288
2021 Q3	$22.6M	Sell	381,800 -26,300	-6%	-$1.73M	0.02%	560
2021 Q2	$27.3M	Sell	408,100 -56,000	-12%	-$3.65M	0.03%	470
2021 Q1	$29.3M	Sell	464,100 -319,700	-41%	-$19.9M	0.04%	383
2020 Q4	$48.6M	Buy	783,800 +102,500	+15%	+$6.3M	0.08%	191
2020 Q3	$41.1M	Sell	681,300 -51,500	-7%	-$3.1M	0.13%	119
2020 Q2	$43.1M	Sell	732,800 -18,600	-2%	-$1.11M	0.2%	83
2020 Q1	$41.9M	Sell	751,400 -138,300	-16%	-$8.45M	0.34%	40
2019 Q4	$57.1M	Buy	889,700 +235,000	+36%	+$13.5M	0.39%	26
2019 Q3	$33.2M	Buy	654,700 +382,100	+140%	+$18M	0.27%	48
2019 Q2	$12.4M	Sell	272,600 -839,700	-75%	-$39.1M	0.11%	186
2019 Q1	$53.1M	Buy	1,112,300 +510,300	+85%	+$25.4M	0.59%	16
2018 Q4	$31.3M	Buy	602,000 +235,300	+64%	+$12.6M	0.27%	56
2018 Q3	$22.8M	Sell	366,700 -11,400	-3%	-$677K	0.18%	103
2018 Q2	$20.9M	Buy	378,100 +129,600	+52%	+$7M	0.18%	90
2018 Q1	$15.7M	Sell	248,500 -347,500	-58%	-$22.4M	0.16%	117
2017 Q4	$36.5M	Buy	596,000 +49,000	+9%	+$3.06M	0.26%	60
2017 Q3	$34.9M	Buy	547,000 +59,000	+12%	+$3.44M	0.32%	40
2017 Q2	$27.2M	Sell	488,000 -17,100	-3%	-$931K	0.28%	54
2017 Q1	$27.5M	Buy	505,100 +248,000	+96%	+$13.6M	0.32%	41
2016 Q4	$15M	Buy	257,100 +80,800	+46%	+$4.42M	0.15%	148
2016 Q3	$9.51M	Buy	176,300 +154,300	+701%	+$9.91M	0.1%	202
2016 Q2	$1.62M	Sell	22,000 -8,400	-28%	-$594K	0.02%	936
2016 Q1	$1.94M	Sell	30,400 -63,200	-68%	-$3.99M	0.03%	787
2015 Q4	$6.44M	Sell	93,600 -174,800	-65%	-$11.6M	0.08%	276
2015 Q3	$15.9M	Buy	268,400 +200,300	+294%	+$12.7M	0.22%	78
2015 Q2	$4.53M	Buy	68,100 +15,000	+28%	+$989K	0.06%	364
2015 Q1	$3.42M	Buy	53,100 +28,900	+119%	+$1.81M	0.05%	389
2014 Q4	$1.43M	Buy	+24,200	New	+$1.36M	0.02%	840

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's BMY Position: Q4 2025 in Review

Group One Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 27,906 shares — an estimated $1.34M sold.

Group One Trading first reported a position in BMY in Q3 2013 and held it in 35 quarters. The position peaked at $20.2M in Q1 2017. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Group One Trading reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Group One Trading sold 27,906 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.34M.
Group One Trading first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 35 quarters.
Group One Trading's Bristol-Myers Squibb position peaked at $20.2M in Q1 2017.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.